High activity regulatory elements
US12104175B2 · kind B2 · utility
0Cited by
0References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 2019 |
| Grant date | Oct 1, 2024 |
| Priority date | — |
| Expiry date | Aug 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions and methods for driving high expression of a transgene. Compositions and methods for driving high expression of a transgene comprising one or more human-derived regulatory elements, which, when operably linked to a transgene, can result in high expression of the transgene in one or more cell types or tissues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.